Cohance Lifesciences Announces 8th AGM on September 17, 2026, with E-voting Facility
Cohance Lifesciences Limited will hold its 8th Annual General Meeting on September 17, 2026. The company has provided a remote e-voting facility from September 14 to September 16, 2026. The cut-off date for e-voting eligibility is September 10, 2026.
This is a standard corporate announcement regarding the AGM and voting procedures, which typically has a low direct impact on the company's stock price or business operations.
The announcement is a routine procedural update regarding the Annual General Meeting and e-voting information, with no specific financial or strategic developments mentioned.
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has announced its 8th Annual General Meeting (AGM) will be held on Thursday, September 17, 2026, at 04:00 p.m. IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
In compliance with the Companies Act, 2013, and relevant SEBI circulars, the AGM notice, along with the Integrated Annual Report for the financial year ended March 31, 2026, was electronically dispatched to members on August 26, 2026. These documents are also available on the company's website (www.cohance.com), the BSE and NSE websites, and the KFintech website.
The company is providing a remote e-voting facility through KFintech. The remote e-voting period commences on September 14, 2026, at 9:00 a.m. IST and concludes on September 16, 2026, at 5:00 p.m. IST. The cut-off date for determining eligibility for e-voting is September 10, 2026. Members can also vote electronically during the AGM if they are attending via VC/OAVM and have not already voted remotely. Detailed instructions for e-voting and AGM participation are available in the AGM Notice and on the websites.
What to do with a filing like this
Cohance Lifesciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Cohance Lifesciences Limited. Read the original for the full detail.